Whitepapers

There’s never been a more exciting time for medical innovation. Since 2015, the industry has exploded, seeing an average of 150 new biotech startups launch

In the world of biotech, regulatory inspections are an ever-looming concern. Health authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines

 Trial Master Files (TMF) provide a place to collect data and store regulatory information surrounding the development of new drugs and devices and are an

It’s hard to believe, but 2023 is soon coming to a close. With the new year right around the corner, now is the perfect time

A fully functioning pharmacovigilance program is essential in any clinical study for a drug, biologic or medical device. If you don’t take the time to

Designing and carrying out clinical trials has remained relatively unchanged over the last 10-20 years; most biopharmas outsource their studies to a single contract research